• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEW
    Legal
    Terms of usePrivacy policyCookie policy

    High Tide Announces Addition to the Horizons Marijuana Life Sciences Index ETF (TSX: HMMJ ) and Results of Annual General Meeting

    7/30/21 6:00:00 AM ET
    $TLRY
    $ACB
    $HITI
    Medicinal Chemicals and Botanical Products
    Health Care
    Medicinal Chemicals and Botanical Products
    Health Care
    Get the next $TLRY alert in real time by email

    CALGARY, AB, July 30, 2021 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (TSXV:HITI) (NASDAQ:HITI) (FRA: 2LYA), a retail-focused cannabis corporation enhanced by the manufacturing and distribution of consumption accessories, today announced that as per the recently disclosed listing of holdings available on its website, the Company's shares have now been included in Horizons Marijuana Life Sciences Index ETF (TSX:HMMJ).

    High Tide Inc. - July 30, 2021 (CNW Group/High Tide Inc.)

    "We are very pleased to have our shares included in the Horizons Marijuana Life Sciences Index ETF," said Raj Grover, President and Chief Executive Officer of High Tide.  "This is yet more recognition of High Tide's continued execution which has now resulted in another high profile institution acquiring our shares since we listed them on the Nasdaq.  This inclusion represents the second new ETF listing for High Tide since our shares began trading on the Nasdaq two months ago," added Mr. Raj Grover.

    Voting Results from Annual General and Special Meeting of Shareholders

    The Company also released voting results from its Annual General and Special Meeting of Shareholders held virtually on Thursday, July 29, 2021 (the "Meeting"). All nominees included in its Notice of Annual General and Special Meeting of Shareholders and Management Information Circular dated June 14, 2021 (the "Circular"), were elected as directors of High Tide.

    The results of the votes were as follows:

    Nominee

    Votes For:

    Votes Withheld:



    Number

    %

    Number

    %

    Harkirat ("Raj") Grover

    6,700,845

    99.92

    5,474

    0.08

    Nitin Kaushal

    6,701,438

    99.93

    4,906

    0.07

    Arthur Kwan

    6,690,168

    99.76

    16,176

    0.24

    Christian Sinclair

    6,702,172

    99.94

    4,172

    0.06

    Andrea Elliott

    6,701,438

    99.93

    4,906

    0.07

    All other resolutions included in the Circular were successfully approved by shareholders at the Meeting, including but not limited to the appointment of Ernst & Young LLP as the Company's auditor, fixing the number of directors at five and to consider the passing of other resolutions if deemed advisable, with or without variation.

    Grant of Restricted Share Units

    The Company also announced that its Board of Directors has approved a grant of 35,000 restricted share units ("RSUs") to an officer of the Company pursuant to the Company's restricted share unit plan. Each RSU entitles the holder to acquire one common share of the Company upon vesting.

    About High Tide Inc.

    High Tide is a retail-focused cannabis company enhanced by the manufacturing and distribution of consumption accessories. The Company is the most profitable Canadian retailer of recreational cannabis as measured by Adjusted EBITDA1, with 88 current locations spanning Ontario, Alberta, Manitoba and Saskatchewan.  High Tide's retail segment features the Canna Cabana, Meta Cannabis Co., Meta Cannabis Supply Co. and NewLeaf Cannabis banners, with additional locations under development across the country. High Tide has been serving consumers for over a decade through its established ecommerce platforms including Grasscity.com, Smokecartel.com and Dailyhighclub.com, and more recently in the hemp-derived CBD space through CBDcity.com and FABCBD.com as well as its wholesale distribution division under Valiant Distribution, including the licensed entertainment product manufacturer Famous Brandz. High Tide's strategy as a parent company is to extend and strengthen its integrated value chain, while providing a complete customer experience and maximizing shareholder value. Key industry investors in High Tide include Tilray Inc. (TSX:TLRY) (NASDAQ:TLRY) and Aurora Cannabis Inc. (TSX:ACB) (NASDAQ:ACB).

    Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.

    For more information about High Tide Inc., please visit www.hightideinc.com and its profile page on SEDAR at www.sedar.com.

    CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

    Certain statements in this news release are forward-looking information or forward-looking statements. Such information and statements, referred to herein as "forward-looking statements" are made as of the date of this news release or as of the date of the effective date of information described in this news release, as applicable. Forward-looking statements relate to future events or future performance and reflect current estimates, predictions, expectations or beliefs regarding future events. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance (generally, forward-looking statements can be identified by use of words such as "outlook", "expects", "intend", "forecasts", "anticipates", "plans", "projects", "estimates", "envisages, "assumes", "needs", "strategy", "goals", "objectives", or variations thereof, or stating that certain actions, events or results "may", "can", "could", "would", "might", or "will" be taken, occur or be achieved, or the negative of any of these terms or similar expressions, and other similar terminology) are not statements of historical fact and may be forward-looking statements.

    Such forward-looking statements are based on assumptions that may prove to be incorrect, including but not limited to the ability of High Tide to execute on its business plan and that High Tide will receive one or multiple licenses from Alberta Gaming, Liquor & Cannabis, British Columbia's Liquor Distribution Branch, Liquor, Gaming and Cannabis Authority of Manitoba, Alcohol and Gaming Commission of Ontario or the Saskatchewan Liquor and Gaming Authority permitting it to carry on its Canna Cabana Inc. and KushBar Inc. businesses. High Tide considers these assumptions to be reasonable in the circumstances. However, there can be no assurance that any one or more of the government, industry, market, operational or financial targets as set out herein will be achieved. Inherent in the forward-looking statements are known and unknown risks, uncertainties and other factors that could cause actual results, performance or achievements, or industry results, to differ materially from any results, performance or achievements expressed or implied by such forward-looking statements.

    The forward–looking statements contained herein are current as of the date of this news release. Except as required by law, High Tide does not have any obligation to advise any person if it becomes aware of any inaccuracy in or omission from any forward-looking statement, nor does it intend, or assume any obligation, to update or revise these forward-looking statements to reflect new events or circumstances. Any and all forward-looking statements included in this news release are expressly qualified by this cautionary statement, and except as otherwise indicated, are made as of the date of this news release.

    ___________________________

    1 Adjusted EBITDA is a non-IFRS financial measure.

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/high-tide-announces-addition-to-the-horizons-marijuana-life-sciences-index-etf-tsx-hmmj--and-results-of-annual-general-meeting-301344893.html

    SOURCE High Tide Inc.

    Get the next $TLRY alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $TLRY
    $ACB
    $HITI

    CompanyDatePrice TargetRatingAnalyst
    Aurora Cannabis Inc.
    $ACB
    12/11/2024Buy
    TD Cowen
    Tilray Brands Inc.
    $TLRY
    4/5/2024$2.25 → $2.75Neutral
    Alliance Global Partners
    Aurora Cannabis Inc.
    $ACB
    2/9/2024Hold → Buy
    Canaccord Genuity
    Tilray Brands Inc.
    $TLRY
    11/2/2022$3.90Mkt Perform
    Bernstein
    Aurora Cannabis Inc.
    $ACB
    9/21/2022Sell → Hold
    Canaccord Genuity
    Tilray Brands Inc.
    $TLRY
    7/29/2022$3.00Hold → Sell
    The Benchmark Company
    Aurora Cannabis Inc.
    $ACB
    6/24/2022Neutral → Overweight
    Cantor Fitzgerald
    Aurora Cannabis Inc.
    $ACB
    6/6/2022Sell → Hold
    Stifel
    More analyst ratings

    $TLRY
    $ACB
    $HITI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Tilray, a Global Leader in Medical Cannabis, Announces Expansion of Premium Craft Cannabis Production at its Advanced EU-GMP Facility in Germany; Tilray Medical Enhances Tilray Craft Cannabis Portfolio with New Patient-Centered Offerings

    NEUMÜNSTER, Germany, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Tilray Medical a division of Tilray Brands, Inc. (NASDAQ:TLRY, TSX:TLRY) and a global leader in medicinal cannabis, empowering the therapeutic alliance between patients and healthcare practitioners to make informed individualized health decisions, transforming healthcare today announced the expansion of its Tilray Craft portfolio in Germany with five new cannabis flower products produced in Germany at Tilray's EU‑GMP certified facility in Neumünster as part of the BfArM in‑country cultivation program. The additions reflect Tilray's ongoing commitment to providing physicians and pharmacies with a diverse range of quality, EU‑GMP certif

    9/30/25 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    High Tide Makes ROB Annual Ranking of Canada's Top Growing Companies for Fifth Consecutive Year

    CALGARY, AB, Sept. 26, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ: HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that it placed No. 182 out of 400 companies listed on the 2025 Report on Business ranking of Canada's Top Growing Companies, with a three-year revenue growth rate of 188%. This follows the Company's 2024 ranking of 87th out of 417 companies, with a three-year growth rate of 486%. "For the fifth consecutive year, High Tide h

    9/26/25 11:30:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    Tilray Brands, Inc. to Announce First Quarter Fiscal Year 2026 Financial Results on October 9, 2025

    NEW YORK and LEAMINGTON, Ontario, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage and wellness industries, today announced that the Company will release its financial results for the first quarter which ended August 31, 2025 before the financial markets open on Thursday, October 9, 2025. Live Conference Call and Audio Webcast Tilray will host a live conference call, which will be webcast, to discuss these results at 8:30 AM Eastern Time on the same day. The webcast can be accessed on the Events & Presentations section of Tilray's In

    9/25/25 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    $TLRY
    $ACB
    $HITI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President and CEO Simon Irwin D exercised 706,216 shares at a strike of $0.58 and covered exercise/tax liability with 374,295 shares, increasing direct ownership by 7% to 4,826,493 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    8/4/25 4:07:08 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Chief Financial Officer Merton Carl A exercised 93,928 shares at a strike of $0.58 and covered exercise/tax liability with 49,782 shares, increasing direct ownership by 5% to 920,497 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    8/4/25 4:06:42 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Global General Counsel Gendel Mitchell exercised 93,928 shares at a strike of $0.58, covered exercise/tax liability with 49,782 shares and bought $3,496 worth of shares (6,000 units at $0.58), increasing direct ownership by 8% to 698,287 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    8/4/25 4:06:19 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    $TLRY
    $ACB
    $HITI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Global General Counsel Gendel Mitchell exercised 93,928 shares at a strike of $0.58, covered exercise/tax liability with 49,782 shares and bought $3,496 worth of shares (6,000 units at $0.58), increasing direct ownership by 8% to 698,287 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    8/4/25 4:06:19 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    President and CEO Simon Irwin D bought $100,106 worth of shares (165,000 units at $0.61), increasing direct ownership by 4% to 3,941,633 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    7/30/25 6:52:32 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Chief Financial Officer Merton Carl A bought $19,939 worth of shares (33,500 units at $0.60), increasing direct ownership by 4% to 798,069 units (SEC Form 4)

    4 - Tilray Brands, Inc. (0001731348) (Issuer)

    7/30/25 3:12:46 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    $TLRY
    $ACB
    $HITI
    SEC Filings

    View All

    SEC Form DEFA14A filed by Tilray Brands Inc.

    DEFA14A - Tilray Brands, Inc. (0001731348) (Filer)

    9/26/25 5:03:28 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form DEF 14A filed by Tilray Brands Inc.

    DEF 14A - Tilray Brands, Inc. (0001731348) (Filer)

    9/26/25 5:01:38 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by High Tide Inc.

    6-K - High Tide Inc. (0001847409) (Filer)

    9/26/25 11:59:53 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    $TLRY
    $ACB
    $HITI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    TD Cowen initiated coverage on Aurora Cannabis

    TD Cowen initiated coverage of Aurora Cannabis with a rating of Buy

    12/11/24 10:35:16 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    Alliance Global Partners reiterated coverage on Tilray with a new price target

    Alliance Global Partners reiterated coverage of Tilray with a rating of Neutral and set a new price target of $2.75 from $2.25 previously

    4/5/24 7:39:50 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    Aurora Cannabis upgraded by Canaccord Genuity

    Canaccord Genuity upgraded Aurora Cannabis from Hold to Buy

    2/9/24 6:09:16 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    $TLRY
    $ACB
    $HITI
    Financials

    Live finance-specific insights

    View All

    Tilray Brands, Inc. to Announce First Quarter Fiscal Year 2026 Financial Results on October 9, 2025

    NEW YORK and LEAMINGTON, Ontario, Sept. 25, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. ("Tilray" or the "Company") (NASDAQ:TLRY, TSX:TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage and wellness industries, today announced that the Company will release its financial results for the first quarter which ended August 31, 2025 before the financial markets open on Thursday, October 9, 2025. Live Conference Call and Audio Webcast Tilray will host a live conference call, which will be webcast, to discuss these results at 8:30 AM Eastern Time on the same day. The webcast can be accessed on the Events & Presentations section of Tilray's In

    9/25/25 7:00:00 AM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    High Tide Reports Financial Results for Third Fiscal Quarter Featuring Record Revenue and Adjusted EBITDA, Along With Positive Free Cash Flow and Net Income

    Same-Store Sales Were Up 7.4% Year Over Year, the Fastest Growth Rate in Two YearsThe Company Reports $7.7 Million in Free Cash Flow in Q3 2025, Up 148% Year Over Year, and 57% SequentiallyThe Company Reports Positive Net Income of $832 Thousand, Up 1% Year Over Year and Marked a Meaningful Reversal Versus a Net Loss of $2.8 Million SequentiallyDuring May 2025 and June 2025, Canna Cabana Held a 12% Share of the Cannabis Retail Market Across the Five Provinces in Which the Company Has a Presence, Up From 11% in the Previous Year1 High Tide Remains the Highest Revenue Generating Cannabis Company Reporting in Canadian Dollars.2 Q3 Annualized Revenue Run Rate Was Approximately $600 MillionCALGAR

    9/15/25 4:00:00 PM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    High Tide Closes Acquisition of a Majority Stake in Remexian Pharma GmbH

    CALGARY, AB, Sept. 2, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, is pleased to announce, that further to its press release dated August 14, 2025 (the "August 14 Release"), the Company has completed the acquisition of a 51% interest in Remexian for an estimated purchase price of €26.4 million, such amount to be finalized in 30 days, once the final closing balance sheet is available, and will have a five-year option to acquire the remaining 49% of Remexian at any time after 24 months. Capitalized terms not otherwise defin

    9/2/25 6:00:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    $TLRY
    $ACB
    $HITI
    Leadership Updates

    Live Leadership Updates

    View All

    High Tide to Become Major Player in German Medical Cannabis Market Through Acquisition of Majority Stake in Remexian Pharma GmbH

    Remexian Generated €65 Million in Revenue in the Last 12 Months Remexian Sold 7 Tonnes of Cannabis Flower in Q2 2025, Representing 16% of the 43 Tonnes Imported into Germany in the Quarter1 CALGARY, AB, Aug. 14, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, announced today that it is entering the fast growing German medical cannabis market by signing a definitive agreement (the "Acquisition Agreement") pursuant to which the Company will acquire 51% of Remexian Pharma GmbH ("Remexian"), for a preliminary estimated purchase

    8/14/25 8:00:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    High Tide Provides Corporate Updates

    CALGARY, AB, Aug. 12, 2025 /PRNewswire/ - High Tide Inc. ("High Tide" or the "Company") (NASDAQ:HITI) (TSXV:HITI) (FSE: 2LYA), the high-impact, retail-forward enterprise built to deliver real-world value across every component of cannabis, is pleased to provide several corporate updates. Germany Update High Tide is pleased to share that it continues to make solid progress on the previously disclosed proposed transaction with a leading German medical cannabis importer and wholesaler. This contemplated transaction is already fully funded following the junior secured loan the Com

    8/12/25 6:00:00 AM ET
    $HITI
    Other Specialty Stores
    Consumer Discretionary

    Aurora Cannabis Inc. Announces Results of 2025 Annual General and Special Meeting

    NASDAQ | TSX: ACB EDMONTON, AB, Aug. 8, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders (the "Meeting") held Friday August 8, 2025 by virtual webcast. The total number of shares represented by shareholders present in person (virtually) and by proxy at the Meeting was 17,736,521 common shares, representing 31.53% of Aurora's issued and outstanding common shares as of the record date.

    8/8/25 5:00:00 PM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    $TLRY
    $ACB
    $HITI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Aurora Cannabis Inc. (Amendment)

    SC 13G/A - AURORA CANNABIS INC (0001683541) (Subject)

    2/14/23 11:28:04 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G/A filed by Tilray Brands Inc. (Amendment)

    SC 13G/A - Tilray Brands, Inc. (0001731348) (Subject)

    2/13/23 1:34:44 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form SC 13G filed by Tilray Brands Inc.

    SC 13G - Tilray Brands, Inc. (0001731348) (Subject)

    2/10/23 4:41:36 PM ET
    $TLRY
    Medicinal Chemicals and Botanical Products
    Health Care